Skip to content
    KNSA stock page

    Kiniksa Pharmaceuticals International, plc

    KNSA · earnings call history

    3 calls analysed
    1. Jun 2026Q2 FY26Jul 28, 2026

      Kiniksa Pharmaceuticals Q2 FY26 — Strong ARCALYST Growth and KPL-387 Phase III Initiation

      Read the brief
    2. Mar 2026Q1 FY26Apr 28, 2026

      Kiniksa Q1 FY26 — ARCALYST Revenue Growth and Pipeline Advancement

      Read the brief
    3. Dec 2025Q4 FY25Feb 24, 2026

      Kiniksa Pharmaceuticals Q4 FY25 — ARCALYST Drives Strong Revenue Growth and Profitability, Pipeline Advances

      Read the brief

    Browse all US companies on the earnings-call register.